OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
822356

Ziyuanyuan Holdings Group Ltd

Medical Equipment, Supplies & DistributionVerified

Ziyuanyuan Holdings Group Ltd has a debt-to-equity ratio of 0.85 and a current ratio of 1.54, indicating moderate liquidity and a balanced short-term solvency position. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The company's profitability is weak, with a return on equity of -3.63% and a return on assets of -1.32%, both significantly below the industry median for Medical Equipment, Supplies & Distribution. This underperformance suggests operational inefficiencies or pricing pressures in its core trading and leasing segments. Ziyuanyuan's revenue is distributed across four segments: Finance Leasing Services, Trading Business, Postpartum Care Services, and Others. The Trading Business and Finance Leasing Services are the primary contributors, with the Postpartum Care Service segment likely representing a smaller but growing portion of the business. The company's geographic exposure is not disclosed in the input data, but its operations are likely concentrated in China given its listing on the Hong Kong Stock Exchange. The company's growth trajectory is uncertain, with no specific revenue growth rates or outlooks provided in the input data. However, the negative net income of CNY 10.7 million in the latest period suggests a challenging operating environment, potentially due to rising costs or declining demand in its core markets. Ziyuanyuan faces moderate liquidity risk due to its negative net cash position and a debt load of CNY 249.3 million. The company's dilution risk is currently low, with no near-term pressure from share issuance or convertible instruments. However, the risk assessment notes that the company's financial leverage could increase if it pursues expansion or acquires new assets. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. However, the company's financial performance and risk profile suggest that investors should monitor its liquidity position and operational improvements closely.

30-day price · 8223-0.09 (-20.0%)
Low$0.35High$0.80Close$0.36As of17 May, 00:00 UTC
Profile
CompanyZiyuanyuan Holdings Group Ltd
Ticker8223.HK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Ziyuanyuan Holdings Group Ltd is an investment holding company primarily engaged in the trading of medical equipment and consumables, with operations in finance leasing services, postpartum care, and information technology services.

Classification. Ziyuanyuan is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Ziyuanyuan Holdings Group Ltd has a debt-to-equity ratio of 0.85 and a current ratio of 1.54, indicating moderate liquidity and a balanced short-term solvency position. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. The company's profitability is weak, with a return on equity of -3.63% and a return on assets of -1.32%, both significantly below the industry median for Medical Equipment, Supplies & Distribution. This underperformance suggests operational inefficiencies or pricing pressures in its core trading and leasing segments. Ziyuanyuan's revenue is distributed across four segments: Finance Leasing Services, Trading Business, Postpartum Care Services, and Others. The Trading Business and Finance Leasing Services are the primary contributors, with the Postpartum Care Service segment likely representing a smaller but growing portion of the business. The company's geographic exposure is not disclosed in the input data, but its operations are likely concentrated in China given its listing on the Hong Kong Stock Exchange. The company's growth trajectory is uncertain, with no specific revenue growth rates or outlooks provided in the input data. However, the negative net income of CNY 10.7 million in the latest period suggests a challenging operating environment, potentially due to rising costs or declining demand in its core markets. Ziyuanyuan faces moderate liquidity risk due to its negative net cash position and a debt load of CNY 249.3 million. The company's dilution risk is currently low, with no near-term pressure from share issuance or convertible instruments. However, the risk assessment notes that the company's financial leverage could increase if it pursues expansion or acquires new assets. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. However, the company's financial performance and risk profile suggest that investors should monitor its liquidity position and operational improvements closely.
Key takeaways
  • Ziyuanyuan's liquidity position is moderate, with a current ratio of 1.54 but a negative net cash position after debt.
  • The company's profitability is weak, with negative returns on equity and assets.
  • Revenue is spread across four segments, with the Trading Business and Finance Leasing Services being the primary contributors.
  • Growth is uncertain, with no clear trajectory provided in the input data.
  • The company's debt load and negative net income raise concerns about its long-term financial stability.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$513.8M
Gross profit$71.3M
Operating income$6.6M
Net income-$10.7M
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets$811.6M
Total liabilities$516.5M
Total equity$295.0M
Cash & equivalents
Long-term debt$249.3M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$295.0M
Net cash-$249.3M
Current ratio1.5
Debt/Equity0.8
ROA-1.3%
ROE-3.6%
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 5 companies
Metric8223Activity
Op margin1.3%13.3% medp25 5.9% · p75 13.5%bottom quartile
Net margin-2.1%8.6% medp25 2.7% · p75 12.7%bottom quartile
Gross margin13.9%64.0% medp25 60.1% · p75 65.6%bottom quartile
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue3.0% medp25 2.7% · p75 4.5%
Debt / equity85.0%69.3% medp25 63.4% · p75 74.5%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 20:28 UTC#56d65175
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 12:54 UTCJob: 6e46135e